Cargando…
Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
Six months after the publication of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequence, a record number of vaccine candidates were listed, and quite a number of them have since been approved for emergency use against the novel coronavirus disease 2019 (COVID-19). This unpreced...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486642/ https://www.ncbi.nlm.nih.gov/pubmed/34624675 http://dx.doi.org/10.1016/j.biopha.2021.112282 |